COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Ketamine Compared to Propofol for Pediatric GI Endoscopy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00614159
Recruitment Status : Completed
First Posted : February 13, 2008
Last Update Posted : July 2, 2009
Information provided by:
State University of New York - Upstate Medical University

Brief Summary:
Elective outpatient endoscopy for children can be safely performed under general anesthesia with either propofol (1) or ketamine (2) infusions. Both infusions have an advantage over general anesthesia with volatile agents because they do not require intubation. The goal of both infusions is to have the patient breath spontaneously without reacting to the endoscopy which is a noxious stimulus. Patient movement, stridor and vomiting are can interrupt the procedure and increase overall OR time. Propofol also carries the added risk of causing apnea. This side effect is not commonly seen with Ketamine. Our hypothesis is that Ketamine's profile makes it a superior drug to Propofol for elective outpatient endoscopy because of reduced profound intra-operative interruptions and faster recovery time. We plan a study of pediatric patients ages 1 to 10 years old undergoing elective outpatient endoscopy. The patients will be randomized to receiving either a Ketamine or Propofol infusion, and the intra-operative interruptions will be documented by the anesthesiologist. The Post Anesthetic Care Unit (PACU) time to recovery will be monitored and recorded by a third party.

Condition or disease Intervention/treatment
Endoscopy Drug: Ketamine Drug: Propofol

Layout table for study information
Study Type : Observational
Estimated Enrollment : 34 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : October 2007
Actual Primary Completion Date : June 2009
Actual Study Completion Date : June 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Group/Cohort Intervention/treatment
GI Endoscopy Drug: Ketamine
Weight based dosage for Peds subjects, used for duration of the endoscopy.

Drug: Propofol
Weight based dosage for Peds subjects, used for duration of the endoscopy.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   1 Year to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Pre-op setting, previously scheduled for GI Endoscopy

Inclusion Criteria:

  • Age 1-10
  • Endoscopy with sedation scheduled

Exclusion Criteria:

  • A history of chronic respiratory disease
  • Upper respiratory infection
  • Developmental delays
  • Dysrhythmias
  • Increased intercranial pressure
  • Any sedatives or narcotics up to 6 weeks prior to procedure.

Layout table for additonal information
Responsible Party: Xiuli Zhang, MD, Upstate Medical University Identifier: NCT00614159    
Other Study ID Numbers: 5545UMU
First Posted: February 13, 2008    Key Record Dates
Last Update Posted: July 2, 2009
Last Verified: June 2009
Keywords provided by State University of New York - Upstate Medical University:
Child age 1-10 years having a GI Endoscopy with sedation
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Sensory System Agents
Peripheral Nervous System Agents
Anesthetics, Dissociative
Excitatory Amino Acid Antagonists
Excitatory Amino Acid Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action